ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease
- PMID: 38472672
- DOI: 10.1245/s10434-024-15175-2
ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease
Similar articles
-
ASO Author Reflections: The Role of Established Prognostic Factors in Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma.Ann Surg Oncol. 2024 Sep;31(9):6199-6200. doi: 10.1245/s10434-024-15391-w. Epub 2024 May 20. Ann Surg Oncol. 2024. PMID: 38767804 Free PMC article. No abstract available.
-
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma.Ann Surg Oncol. 2024 Oct;31(10):7074-7075. doi: 10.1245/s10434-024-15853-1. Epub 2024 Jul 17. Ann Surg Oncol. 2024. PMID: 39020113 Free PMC article. No abstract available.
-
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.Ann Surg Oncol. 2020 Oct;27(10):3913-3914. doi: 10.1245/s10434-020-08572-w. Epub 2020 May 12. Ann Surg Oncol. 2020. PMID: 32399766 No abstract available.
-
[Ductal adenocarcinoma of the head of the pancreas: a critical study of R1 resection rates].Bull Cancer. 2008 Dec;95(12):1193-8. doi: 10.1684/bdc.2008.0762. Bull Cancer. 2008. PMID: 19091653 Review. French.
-
What is the Value of Total Mesopancreas Excision in Pancreatic Ductal Adenocarcinoma? Current Evidence of the Literature.Chirurgia (Bucur). 2018 May-Jun;113(3):335-343. doi: 10.21614/chirurgia.113.3.335. Chirurgia (Bucur). 2018. PMID: 29981664 Review.
References
-
- Groot VP, Gemenetzis G, Blair AB, et al. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000002734 . - DOI - PubMed
-
- Valle JW, Palmer D, Jackson R, et al. Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol. 2014;32:504–12. https://doi.org/10.1200/JCO.2013.50.7657 . - DOI - PubMed
-
- Belfiori G, Crippa S, Pagnanelli M, et al. Very early recurrence after curative resection for pancreatic ductal adenocarcinoma: proof of concept for a “biological r2 definition.” Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15105-2 . - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical